Atlas Trials

An Observational Study on The Impact of Insulin Resistance on Sustained Virological Response in Patients With Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)

Clinical trial NCT01200225 · COMPLETED

Trial details

NCT number
NCT01200225
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Study type
OBSERVATIONAL
Hepatitis C, Chronic
Start date
2010-02-01
Primary completion
2013-06-01
Enrollment
1155

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.